Noom, an app that helps people track their eating and exercise habits, will now offer prescriptions through a new telehealth platform known as Noom Med.
." "And if people want to lose weight and they center that as the thing that's valuable, we're going to see more companies jump on the bandwagon and start to use these GLP-1s."
Both drugs are made from a compound called semaglutide, which works by helping the pancreas release insulin to move sugar from the blood into body tissues. The combination is said to slow the emptying of the stomach by making people feel full longer, suppress appetite by slowing hunger signals to the brain, and help reduce blood sugar.Mario Tama/Getty Images, FILE
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Weight-loss drugs may also curb addictionsWeight-loss medications like Ozempic aren’t just helping people shed pounds.
Baca lebih lajut »
Opinion | One reason for the surprise jobs boom? Immigrants are back.Opinion by Catherine Rampell: Foreign-born workers and women are punching above their weight in the labor market.
Baca lebih lajut »
‘Ozempic Butt’ is becoming a problem for some trying to lose weight with popular drugFirst there was 'Ozempic Face' and now, apparently, there is 'Ozempic Butt.'
Baca lebih lajut »
Five tips on how to lose weight and why it's important | Medical ViewsIndividuals who are overweight have a higher incidence of diabetes, high blood pressure, stroke, high cholesterol, heart disease and selected cancer.
Baca lebih lajut »
Ozempic and Wegovy force weight loss companies to upend their approachesThe growing popularity of obesity and diabetes drugs Wegovy and Ozempic is inspiring other weight-loss companies to fundamentally shift their business models.
Baca lebih lajut »